Lesley Ann Calhoun's Net Worth
$2.07 Million
Who is Lesley Ann Calhoun?
Lesley Ann Calhoun has an estimated net worth of $2.07 Million. This is based on reported shares across multiple companies, which include Tango Therapeutics, Inc., Global Blood Therapeutics, Inc., and Aligos Therapeutics, Inc..
SEC CIK
Lesley Ann Calhoun's CIK is 0001730866
Past Insider Trading and Trends
2018 was Lesley Ann Calhoun's most active year for acquiring shares with 10 total transactions. Lesley Ann Calhoun's most active month to acquire stocks was the month of January. 2018 was Lesley Ann Calhoun's most active year for disposing of shares, totalling 14 transactions. Lesley Ann Calhoun's most active month to dispose stocks was the month of January. 2020 saw Lesley Ann Calhoun paying a total of $613,208.80 for 229,935 shares, this is the most they've acquired in one year. In 2020 Lesley Ann Calhoun cashed out on 60,054 shares for a total of $2,277,151.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tango Therapeutics, Inc. (TNGX) Snapshot price: $10.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +225.00% | 11.25K |
$7.21 | $36,039.00 | 6.25K |
Jun 5
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Global Blood Therapeutics, Inc. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$49.93 | -$108,945.00 | 154 |
May 26
| |||
Form 4
|
—
|
0
|
$48.34 | -$1,228,791.10 | 154 |
May 18
| |||
Form 4
| -95.63% | -3.37K |
$78.23 | -$263,868.11 | 154 |
May 11 - May 12
| |||
Form 4
| +5.88% | 196 |
$63.96 | -$6,651.84 | 3.53K |
Mar 1
| |||
Form 4
| +275.54% | 2.44K |
$50.97 | -$75,310.04 | 3.33K |
Jan 31 - Feb 3
| |||
Form 4
| -75.71% | -2.77K |
$54.36 | -$150,296.28 | 887 |
Sep 11
| |||
Form 4
| +5.67% | 196 |
$45.98 | -$4,781.92 | 3.65K |
Sep 1
| |||
Form 4
| +181.43% | 2.23K |
$45.47 | -$57,505.00 | 3.46K |
Jul 31 - Aug 1
| |||
Form 4
| +18.99% | 196 |
$53.48 | -$5,561.92 | 1.23K |
Mar 1
| |||
Form 4
|
—
|
0
|
$43.57 | -$4,875.64 | 1.03K |
Jan 31 - Feb 12
| |||
Form 4
| +42.84% | 443 |
$48.44 | -$14,871.08 | 1.48K |
Feb 1
| |||
Form 4
| +23.39% | 196 |
$48.95 | -$5,090.80 | 1.03K |
Sep 1 - Sep 4
| |||
Form 4
| -26.36% | -300.00 |
$36.76 | -$59,722.21 | 838 |
Jul 31 - Aug 17
| |||
Form 4
| +193.30% | 750 |
—
|
—
| 1.14K |
Aug 1
| |||
Form 4
|
—
|
0
|
$33.10 | -$73,123.83 | 388 |
Jul 6 - Jul 9
| |||
Form 4
| +107.49% | 201 |
$60.35 | -$5,974.65 | 388 |
Mar 1 - Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||